av/transmedics--big.svg

NASDAQ:TMDX

Transmedics

  • Stock

USD

Last Close

124.98

06/11 22:28

Market Cap

4.56B

Beta: 1.44

Volume Today

701.42K

Avg: 546.15K

PE Ratio

−79.07

PFCF: −120.15

    Description

    TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate nea...Show More

    Earnings

    Earnings per Share (Estimate*)

    -5-4-3-2-12018-06-292019-08-072021-08-052023-08-032024-07-31

    Revenue (Estimate*)

    20M40M60M80M100M120M2018-06-292019-08-072021-08-052023-08-032024-07-31

    *Estimate based on analyst consensus